Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery.

The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Abstract Text:

    chirag dholakiaChirag Dholakia,gretchen beversteinGretchen Beverstein,michael garrenMichael Garren,christopher nemergutChristopher Nemergut,john boncykJohn Boncyk,jon c gouldJon C Gould,chirag dholakiaChirag Dholakia,gretchen beversteinGretchen Beverstein,michael garrenMichael Garren,christopher nemergutChristopher Nemergut,john boncykJohn Boncyk,jon c gouldJon C Gould,chirag dholakiaChirag Dholakia,gretchen beversteinGretchen Beverstein,michael garrenMichael Garren,christopher nemergutChristopher Nemergut,john boncykJohn Boncyk,jon c gouldJon C Gould,

    Dexmedetomidine (Precedex, Hospira, Lake Forest, IL) is an alpha-2 receptor agonist with sedative and analgesic sparing properties. This medication has not been associated with respiratory suppression, despite occasionally high levels of sedation. For 10 months, all patients undergoing a laparoscopic bariatric procedure received a dexmedetomidine infusion 30 min before the anticipated completion of the procedure (n = 34). A control group was comprised of a similar number of patients to have had laparoscopic bariatric surgery in the time period immediately before these 10 months (n = 37). All pathways and discharge criteria were identical for patients in each group. A total of 73 patients were included in this retrospective chart review. Two gastric bypass patients were excluded for complications requiring additional surgery (one bleed and one leak). Gastric bypass patients who received a dexmedetomidine infusion required fewer narcotics (66 vs 130 mg of morphine equivalents) than control patients and met discharge criteria on post-op day (POD) 1 more often (61% discharged POD 1 vs 26% discharged POD 1, p = 0.02). Vital signs and pain scores were similar in all groups. Dexmedetomidine infusion perioperatively is safe and may help to minimize narcotic requirements and decrease duration of stay after laparoscopic bariatric procedures. This may have important patient safety ramifications in a patient population with a high prevalence of obstructive sleep apnea. A well-organized prospective, randomized, double-blinded trial is necessary to confirm the benefits of dexmedetomidine suggested by this study.

    The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Publishing Authors By Initials

    c dholakiaC Dholakia,g beversteinG Beverstein,m garrenM Garren,c nemergutC Nemergut,j boncykJ Boncyk,jc gouldJC Gould,c dholakiaC Dholakia,g beversteinG Beverstein,m garrenM Garren,c nemergutC Nemergut,j boncykJ Boncyk,jc gouldJC Gould,c dholakiaC Dholakia,g beversteinG Beverstein,m garrenM Garren,c nemergutC Nemergut,j boncykJ Boncyk,jc gouldJC Gould,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of gastrointestinal surgery : official jou

    VOLUME: 11

    Page Numbers: 1556-9

    Journal Abbreviation: J. Gastrointest. Surg.

    ISSN: 1091-255X

    DAY: 21

    MONTH: 08

    YEAR: 2007

    The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9706084

    The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery.

    AFFILIATION: Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Gastrointest Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News